KYMRNasdaq United States
Market cap
$8.940 B
$107.52 +1.04%
Close of 7 Aug 2026
Revenue
$39.2M
#2818 by revenue
Earnings
$311.4M
#822 by earnings
Shares outstanding
83,150,618
Latest filing cover page
P/E ratio
28.7
Cap ÷ net income
Where these numbers come from
Share counts and financials for Kymera Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.